Clinical Trial Update: A Study of LY3113593 in Healthy Participants and Participants With Chronic Kidney Disease Treated With Hemodialysis [Phase 1]

View source ↗

Summary

Phase 1 study of LY3113593 in healthy participants and in patients with chronic kidney disease on hemodialysis, with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• LY3113593

Snippet

Sponsor: Eli Lilly and Company | Conditions: Kidney Failure, Chronic | Phase 1 | Status: COMPLETED | Results posted: 2019-01-22